Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
17.06
-0.13 (-0.73%)
Nov 18, 2026, 1:13 PM EST - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $2.01 billion as of November 18, 2026. It is the 6,327th most valuable company in the world and the 1,709th biggest in the United States. Its market cap has increased by 21.11% in one year.
Market Cap
2.01B
Enterprise Value
1.56B
1-Year Change
21.11%
Global Rank
Country Rank
#1,709 United States
Category
ChartMarket Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.01B, an increase of 1,707.81%. That is a compound annual growth rate of 60.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 2.01B | -15.03% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 2.11B |
| Aurinia Pharmaceuticals | 2.06B |
| Beam Therapeutics | 2.06B |
| Biohaven | 2.00B |
| Harmony Biosciences Holdings | 1.94B |
| Trevi Therapeutics | 1.93B |
| Septerna | 1.90B |
| Vera Therapeutics | 1.89B |